ADL BioPharma strengthens its financial position to undertake new investments
ADL BioPharma is carrying out a new capital increase of 12 million euros in order to reinforce its equity position and provide the financial strength to execute its Strategic Growth Plan. This increase has been signed 100% by its sole shareholder, Kartesia. In...
Capital Energy and ADL BioPharma sign a renewable energy provision contract and become strategic partners
Within the framework of both companies’ commitment to sustainable development Capital Energy will provide 61,000 megawatts hour (MWh) per year of clean and competitive power to this emblematic Leonese biotechnology company premises over the next five years....
ADL BioPharma renewed its “GMP food” certification
Last June, ADL BioPharma renewed its “GMP food” certification in compliance with the CODEX Alimentarius, for production through fermentation and recovery processes. In addition, it extends and certifies this quality system to its Fermentation Pilot Plant and the...
ADL’s pilot plant resumes its activity with two important projects
At the beginning of 2021 ADL resumed activity in the pilot plant in which the technology transfer of two projects is currently being carried out. One of them aims to produce a high-value product in the cosmetic industry, and the other focuses on the production of a...
